24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension
27 August 2021
ESC Premium Access
Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage
27 August 2021
ESC Premium Access
Major arterial and venous thromboembolic complications in patients with covid-19